The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Two cycles of neoadjuvant therapy with low-dose radiotherapy, PD-1 inhibitor tislelizumab, albumin-bound paclitaxel, and cisplatin for resectable locally advanced head and neck squamous cell carcinoma (NeoRTPC02): A phase II, open-label, single-arm trial.
 
Zhigang Liu
No Relationships to Disclose
 
Dong Wang
No Relationships to Disclose
 
Guanjun Li
No Relationships to Disclose
 
Muhua Yi
No Relationships to Disclose
 
Zhaoyuan Zhang
No Relationships to Disclose
 
Guihua Zhong
No Relationships to Disclose
 
Yingpeng Peng
No Relationships to Disclose
 
Lizhong Liang
No Relationships to Disclose
 
Jianpeng Li
No Relationships to Disclose
 
Ye Liu
No Relationships to Disclose
 
Jun Lai
No Relationships to Disclose
 
Xianjuan Lv
No Relationships to Disclose
 
Yongqiang Xu
No Relationships to Disclose
 
Qiandan Liu
No Relationships to Disclose
 
Zhiqiang Wang
No Relationships to Disclose
 
Zhutian Liu
No Relationships to Disclose
 
Qinan Yang
No Relationships to Disclose
 
Li Nie
No Relationships to Disclose
 
Jiao Lei
No Relationships to Disclose
 
Zhijie Liu
No Relationships to Disclose
 
Zhigang Liu LDRT
No Relationships to Disclose